Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AKTX

Akari Therapeutics Plc ADR

10.73

Jun 26 • 04:00PM ET +1.21 (12.71%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-18.86	Insider Own	0.40%	Shs Outstand	1.14M	Perf Week	-1.92%
Market Cap	12.23M	Forward P/E	-	EPS next Y	-4.68	Insider Trans	0.00%	Shs Float	1.14M	Perf Month	-32.62%
Enterprise Value	10.13M	PEG	-	EPS next Q	-1.39	Inst Own	14.65%	Short Float	3.95%	Perf Quarter	96.66%
Income	-28.00M	P/S	-	EPS this Y	72.10%	Inst Trans	-96.22%	Short Ratio	0.06	Perf Half Y	9.36%
Sales	0.00M	P/B	0.85	EPS next Y	18.89%	ROA	-66.00%	Short Interest	0.05M	Perf YTD	-7.18%
Book/sh	12.56	P/C	4.32	EPS next 5Y	32.82%	ROE	-155.01%	52W High	49.60 -78.37%	Perf Year	-77.07%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	- -	ROIC	-194.71%	52W Low	3.02 255.89%	Perf 3Y	-91.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	14.24% 20.74%	Perf 5Y	-99.24%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.85%	Oper. Margin	-	ATR (14)	2.13	Perf 10Y	-99.90%
Dividend Ex-Date	-	Quick Ratio	0.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.85	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.27	EPS Q/Q	-75.83%	SMA20	-19.57%	Beta	1.44	Target Price	27.00
Payout	-	Debt/Eq	0.05	Sales Q/Q	-	SMA50	13.37%	Rel Volume	0.12	Prev Close	9.52
Employees	6	LT Debt/Eq	0.00	Earnings	May 14	SMA200	-30.69%	Avg Volume	779.14K	Price	10.73
IPO	May 07, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	91,545	Change	12.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)